Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
Breast. 2012 Feb;21(1):77-82. doi: 10.1016/j.breast.2011.08.001. Epub 2011 Sep 8.
We updated trends in breast cancer mortality in Europe up to the late 2000's. In the EU, age-adjusted (world standard population) breast cancer mortality rates declined by 6.9% between 2002 and 2006, from 17.9 to 16.7/100,000. The largest falls were in northern European countries, but more recent declines were also observed in central and eastern Europe. In 2007, all major European countries had overall breast cancer rates between 15 and 19/100,000. In relative terms, the declines in mortality were larger at younger age (-11.6% at age 20-49 years between 2002 and 2007 in the EU), and became smaller with advancing age (-6.6% at age 50-69, -5.0% at age 70-79 years). The present report confirms and further quantifies the persisting steady fall in breast cancer mortality in Europe over the last 25-30 years, which is mainly due to advancements in the therapy.
我们更新了截至 2000 年代后期欧洲乳腺癌死亡率的趋势。在欧盟,2002 年至 2006 年间,年龄标准化(世界标准人口)乳腺癌死亡率从 17.9/100,000 下降了 6.9%,至 16.7/100,000。北欧国家的降幅最大,但最近中欧和东欧也观察到了下降。2007 年,所有主要欧洲国家的总体乳腺癌发病率均在 15 至 19/100,000 之间。从相对角度来看,死亡率的降幅在较年轻的年龄组更大(2002 年至 2007 年间,欧盟 20-49 岁年龄组的死亡率下降了 11.6%),而随着年龄的增长,降幅逐渐减小(50-69 岁年龄组为 6.6%,70-79 岁年龄组为 5.0%)。本报告证实并进一步量化了过去 25-30 年来欧洲乳腺癌死亡率持续稳定下降的趋势,这主要归因于治疗方法的进步。